Carisoprodol — 350MG, Tablet, bottle of 100 tablets

Carisoprodol — 350MG, Tablet, bottle of 100 tablets

Carisoprodol is a tablet for oral use. Carisoprodol is indicated for the relief of discomfort associated with acute, painful musculoskeletal conditions in adults. Limitation of Use Carisoprodol should only be used for short periods (up to two or three weeks) because adequate evidence of effectiveness for more prolonged use has not been established and because acute, painful musculoskeletal conditions are generally of short duration. [ see Dosage and Administration (2) ].

• Active ingredient or product type: CARISOPRODOL
• Strength/concentration: 350MG
• Dosage form and route: Tablet, Oral
• Exact package presentation: bottle of 100 tablets
• NDC/item number: 50228-109-01
• Manufacturer: SCIEGEN PHARMACEUTICALS INC
• Storage/handling: Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature].
• Status: Rx only

Important safety information: Due to sedative properties, may impair ability to perform hazardous tasks such as driving or operating machinery (5.1) Additive sedative effects when used with other CNS depressants including alcohol (5.1) Cases of abuse, dependence and withdrawal (5.2 , 9.2 , 9.3) Seizures (5.3) 5.1 Sedation Carisoprodol has sedative properties (in the low back pain trials, 13% to 17% of patients who received carisoprodol experienced sedation compared to 6% of patients who received placebo) [ see ADVERSE REACTI

Refer to the current product labeling for complete indications, preparation or administration instructions, contraindications, warnings, precautions, and storage requirements.